Birchview Capital’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-170,303
| Closed | -$2.97M | – | 56 |
|
|
2020
Q4 | $2.97M | Hold |
170,303
| – | – | 1.71% | 10 |
|
|
2020
Q3 | $1.99M | Hold |
170,303
| – | – | 1.33% | 13 |
|
|
2020
Q2 | $2.21M | Hold |
170,303
| – | – | 1.34% | 11 |
|
|
2020
Q1 | $1.58M | Hold |
170,303
| – | – | 1.4% | 12 |
|
|
2019
Q4 | $2.83M | Hold |
170,303
| – | – | 2.05% | 5 |
|
|
2019
Q3 | $2.83M | Buy |
170,303
+30,000
| +21% | +$415K | 1.89% | 6 |
|
|
2019
Q2 | $1.93M | Buy |
140,303
+60,000
| +75% | +$918K | 1.17% | 9 |
|
|
2019
Q1 | $1.38M | Hold |
80,303
| – | – | 0.87% | 10 |
|
|
2018
Q4 | $1.03M | Sell |
80,303
-20,000
| -20% | -$303K | 0.97% | 11 |
|
|
2018
Q3 | $1.63M | Sell |
100,303
-57,000
| -36% | -$815K | 1.05% | 9 |
|
|
2018
Q2 | $2.03M | Sell |
157,303
-20,000
| -11% | -$270K | 1.38% | 9 |
|
|
2018
Q1 | $2.21M | Buy |
177,303
+50,000
| +39% | +$609K | 1.45% | 5 |
|
|
2017
Q4 | $1.78M | Buy |
127,303
+50,000
| +65% | +$732K | 1.04% | 7 |
|
|
2017
Q3 | $1.3M | Buy |
77,303
+10,000
| +15% | +$163K | 0.67% | 10 |
|
|
2017
Q2 | $1.13M | Hold |
67,303
| – | – | 0.6% | 8 |
|
|
2017
Q1 | $1.04M | Hold |
67,303
| – | – | 0.58% | 11 |
|
|
2016
Q4 | $1.01M | Hold |
67,303
| – | – | 0.62% | 10 |
|
|
2016
Q3 | $845K | Buy |
67,303
+11,000
| +20% | +$110K | 0.49% | 14 |
|
|
2016
Q2 | $507K | Hold |
56,303
| – | – | 0.37% | 20 |
|
|
2016
Q1 | $558K | Buy |
56,303
+16,000
| +40% | +$164K | 0.4% | 17 |
|
|
2015
Q4 | $463K | Buy |
40,303
+25,000
| +163% | +$309K | 0.27% | 24 |
|
|
2015
Q3 | $207K | Buy |
+15,303
| New | +$207K | 0.13% | 38 |
|
Birchview Capital's OXFD Position: Q1 2021 in Review
Birchview Capital sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 170,303 shares — an estimated $2.97M sold.
Birchview Capital first reported a position in OXFD in Q3 2015 and held it in 22 quarters. The position peaked at $2.97M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- Birchview Capital reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- Birchview Capital sold 170,303 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $2.97M.
- Birchview Capital first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2015 and held it in 22 quarters.
- Birchview Capital's Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.97M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on Birchview Capital's 13F filing for Q1 2021, filed 14 May 2021.